MNDL Bio

MNDL Bio accelerates recombinant protein development with an AI-powered platform for gene expression optimization. By replacing trial-and-error with data-driven predictions, MNDL Bio helps researchers design high-yield gene sequences faster, reducing costs and development time. Its cloud-based SaaS platform offers flexible service tiers for startups, academic labs, and biopharma companies, enabling smarter experimental designs and faster product development in synthetic biology.